🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Hormone replacement therapy is effective for relieving symptoms ...
Status
Completed
Location
Helsinki University Central Hospital
Start Date
1997-09
Trial ID
NCT00003771
Treatments Being Tested
The purpose of this clinical trial to characterize changes in bone mineral ...
Status
Recruiting
Location
Mobile
Start Date
2023-08-14
Trial ID
NCT05862272
Treatments Being Tested
The primary objective of this study is to demonstrate the superior efficacy...
Status
Unknown
Location
Site no.28
Start Date
2022-12-16
Trial ID
NCT05620355
Treatments Being Tested
The purpose of this research study is to demonstrate a lack of effect of mu...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00504816
The purpose of this study is to determine the benefit of relugolix 40 milli...
Status
Completed
Location
Birmingham
Start Date
2017-06-14
Trial ID
NCT03103087
The purpose of this study is to learn if women taking the atazanavir and ri...
Status
Completed
Location
Los Angeles County Hospital University of Southern California (LAC USC)
Start Date
2012-06
Trial ID
NCT01667978
Treatments Being Tested
The study is designed to investigate the safety of the investigational prod...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00522873
Treatments Being Tested
The purpose of this study was to assess the contraceptive efficacy of a nom...
Status
Terminated
Location
Multiple Locations
Start Date
2012-11-02
Trial ID
NCT01656434
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to determine th...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT01477632
The purpose of this study is to determine if the addition of Low Dose Naltr...
Status
Terminated
Location
Penn State Hershey Medical Center
Start Date
2020-01-16
Trial ID
NCT03970330
Treatments Being Tested